Osaic Holdings’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2 | Hold |
5
| – | – | ﹤0.01% | 7234 |
|
2025
Q1 | $1 | Sell |
5
-27
| -84% | -$5 | ﹤0.01% | 7229 |
|
2024
Q4 | $16 | Buy |
32
+5
| +19% | +$3 | ﹤0.01% | 7150 |
|
2024
Q3 | $87 | Hold |
27
| – | – | ﹤0.01% | 7025 |
|
2024
Q2 | $81 | Hold |
27
| – | – | ﹤0.01% | 7051 |
|
2024
Q1 | $126 | Hold |
27
| – | – | ﹤0.01% | 6823 |
|
2023
Q4 | $112 | Hold |
27
| – | – | ﹤0.01% | 6942 |
|
2023
Q3 | $81 | Hold |
27
| – | – | ﹤0.01% | 7066 |
|
2023
Q2 | $66 | Sell |
27
-29
| -52% | -$71 | ﹤0.01% | 7152 |
|
2023
Q1 | $127 | Sell |
56
-721
| -93% | -$1.64K | ﹤0.01% | 7172 |
|
2022
Q4 | $3K | Sell |
777
-4,850
| -86% | -$18.7K | ﹤0.01% | 6485 |
|
2022
Q3 | $208K | Buy |
5,627
+850
| +18% | +$31.4K | ﹤0.01% | 3697 |
|
2022
Q2 | $91K | Buy |
4,777
+1,875
| +65% | +$35.7K | ﹤0.01% | 4495 |
|
2022
Q1 | $79K | Buy |
2,902
+2,800
| +2,745% | +$76.2K | ﹤0.01% | 4763 |
|
2021
Q4 | $3K | Sell |
102
-707
| -87% | -$20.8K | ﹤0.01% | 6768 |
|
2021
Q3 | $21K | Buy |
809
+286
| +55% | +$7.42K | ﹤0.01% | 5727 |
|
2021
Q2 | $17K | Buy |
523
+198
| +61% | +$6.44K | ﹤0.01% | 5743 |
|
2021
Q1 | $12K | Hold |
325
| – | – | ﹤0.01% | 5756 |
|
2020
Q4 | $10K | Hold |
325
| – | – | ﹤0.01% | 5475 |
|
2020
Q3 | $12K | Buy |
325
+250
| +333% | +$9.23K | ﹤0.01% | 5165 |
|
2020
Q2 | $3K | Hold |
75
| – | – | ﹤0.01% | 5613 |
|
2020
Q1 | $3K | Buy |
+75
| New | +$3K | ﹤0.01% | 5487 |
|